HOME >> MEDICINE >> NEWS
Study finds significant reduction in respiratory illnesses in babies breastfed six months vs. four

(SACRAMENTO, Calif.) -- Babies fully breastfed for six months are less likely to suffer from respiratory illnesses in their first two years than babies fully breastfed for only four months, according to research conducted by investigators at UC Davis Children's Hospital, the University of Rochester and the American Academy of Pediatrics, Center for Child Health Research.

"We found that babies who received an additional two months of full breastfeeding were over four times less likely to contract pneumonia and half as likely to suffer recurrent ear infections," said lead author Caroline Chantry, a pediatrician with UC Davis Children's Hospital. Chantry and her colleagues found that the health benefits of the additional two months of full breastfeeding continued to protect babies from respiratory illnesses through their second birthdays.

"This finding adds to the mounting evidence that the longer a mother breastfeeds her infant, the greater the health benefits," Chantry said. Previous research by others has shown that exclusive breastfeeding for six months also provides greater protection against gastrointestinal infections, she added.

The current findings appear in the February 2006 issue of Pediatrics. They were first reported in 2002 at a joint meeting of the Pediatric Academic Societies and American Academy of Pediatrics in Baltimore, Md. Since then, those preliminary findings have been used to support the recommendation that women breastfeed exclusively for the first six months of their baby's lives. The AAP first began making that recommendation in 1997.

As recently as 2005, however, the AAP Committee on Nutrition said more research was needed to support the position on breastfeeding. Chantry said she hopes the peer-reviewed publication of her research will finally settle the lingering controversy over the advice American women receive from their physicians and organizations like the AAP.

In the published study, Chantry an
'"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916 734-9064
University of California, Davis - Health System
6-Feb-2006


Page: 1 2 3

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology:
Cached News: